Interferon-bèta Enhances Sensitivity to Gemcitabine in Pancreatic Cancer
Amber Blaauboer(Erasmus MC), Leo J. Hofland(Erasmus MC)
Cited by 0
Related Papers
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
|Endocrine Reviews|2003|475
Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors
|Endocrine Related Cancer|2014|25
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
|BMC Cancer|2020|16
Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment
|Cancers|2022|4
Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
|Research Square|2020|0